论文部分内容阅读
目的观察辛伐他汀和血脂康治疗高脂血症的临床疗效。方法本研究共纳入门诊患者141例,根据患者门诊号码将奇数号码患者72例纳入辛伐他汀组,偶数号码患者69例纳入血脂康组。辛伐他汀组予口服辛伐他汀10mg,每晚一次;血脂康组予口服血脂康0.6g,每日早晚各一次。疗程均为8周,治疗前及治疗8周后,分别空腹抽血查TC、TG、LDL-C、HDL-C。结果比较治疗前及治疗8周后TC、TG、LDL-C、HDL-C水平,组内比较差异有统计学意义(P<0.05),两组间比较差异无统计学意义(P>0.05)。结论辛伐他汀与血脂康治疗高脂血症8周,疗效相当。
Objective To observe the clinical effects of simvastatin and Xuezhikang in the treatment of hyperlipidemia. Methods A total of 141 outpatients were enrolled in this study. According to the outpatient number, 72 patients with odd numbers were included in simvastatin group and 69 patients with even numbers were included in Xuezhikang group. Simvastatin group was given oral simvastatin 10mg once night; Xuezhikang group was given oral Xuezhikang 0.6g, daily morning and evening. The course of treatment was 8 weeks. Before treatment and 8 weeks after treatment, fasting blood TC, TG, LDL-C and HDL-C were detected respectively. Results The levels of TC, TG, LDL-C and HDL-C before and 8 weeks after treatment were significantly different between the two groups (P <0.05). There was no significant difference between the two groups (P> 0.05) . Conclusion Simvastatin and Xuezhikang treatment of hyperlipidemia for 8 weeks, the effect is quite.